Diagnostics Manufacturing During COVID-19

SCHOTT MINIFAB COVID-Safe Operations

Fully Operational. No expected interruptions to product or service delivery.

SCHOTT MINIFAB is dedicated to maintaining safe, healthy, and productive operations during COVID-19.

As a result of our continuous effort to mitigate the effects of COVID-19 on business operations, we are pleased to confirm that there are no current or future interruptions expected to product or service delivery.

COVID SAFE PLAN

All SCHOTT MINIFAB sites operate under a COVID-Safe plan. Each plan is site-specific and incorporates:

Strict compliance with local government regulations and health orders;

Administrative measures;

Engineering and social distancing measures;

Hygiene and use of PPE;

Staff training, well-being, and communications programs.

SCHOTT MINIFAB Melbourne

SITE STATUS: Scoresby, Victoria, Australia

Our head office and manufacturing facility is fully operational.

Although local government “Stage 4” restrictions have affected some businesses in the region, SCHOTT MINIFAB has been exempted from such restrictions as a manufacturer of medical and pharmaceutical products.

Staff operating in Scoresby work on a mixture of on-site and work from home arrangements depending on their role.

Fully Operational
SCHOTT MINIFAB Jena, Germany

SITE STATUS: Jena, Germany

Our centre for glass excellence in Jena, Germany, is fully operational.

Staff operating in Jena work on a mixture of on-site and work from home arrangements depending on their role.

Fully Operational
SCHOTT MINIFAB San Francisco

SITE STATUS: San Francisco, USA

Our sales and project support activities in San Francisco, USA, are fully operational via a work-from-home model.

Fully Operational

Contact

Further Information: For further information on our COVID-Safe operations, please contact us.

Latest News from Minifab

SARS-CoV-2 IgG Rapid Antigen Test
May 25, 2021

Qorvo Omnia™ SARS-CoV-2 Antigen Test

in Point of Care
In April 2021, Qorvo were granted emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the Qorvo Omnia™ SARS-CoV-2 Antigen Test. The EUA approval is a major milestone in the collaboration between Qorvo and SCHOTT MINIFAB over the past two years. READ MORE
April 27, 2021

WATCH FREE WEBINAR: Point-of-Care diagnostic consumable development: The importance of biochemistry expertise

in Events
FREE WEBINAR - 3 x 20 MINUTE EXPERT SESSIONS Point-of-Care diagnostic consumable development: Don’t underestimate the importance of biochemistry expertise! It is without question that the global pandemic has created an explosion in the demand for automated point-of-care consumables. In the face of this demand, the race to launch new innovative diagnostics has never been run at a faster pace. However, significant challenges remain in translating lab-based assays onto automated high-performance… READ MORE
February 11, 2021

Case Study Webinar: Rapid Development and Manufacturing Scaleup of a Point-of-Care COVID-19 Test

in Events
Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. READ MORE
December 08, 2020

SCHOTT MINIFAB - IVD Microfluidics Webinar

in Events
What does it take to create a successful microfluidic diagnostic device? Learn from the world leaders in both glass and polymer. 9am CET 18 December 2020. Limited places so register now. READ MORE

Subscribe for email updates

Stay up to date with the latest news, case studies and annoucements from Minifab.